BPC-157 Capsules: The Science of Oral Gastric Cytoprotection
The Biochemistry of Stable BPC-157 Capsules
Standard BPC-157 is susceptible to rapid degradation by gastric acid. However, BPC-157 Capsules typically feature the Arginine Salt or a specialized enteric coating to ensure the peptide remains bioactive as it traverses the digestive tract. This “stable” version allows the peptide to maintain its structural integrity for over five hours in human gastric juice, whereas the standard acetate version degrades in minutes. This stability is critical for research focusing on the peptide’s ability to interact with the mucosal lining of the stomach and intestines.
Mechanism of Action: Promoting the “Wound Healing Cascade”
In advanced gastrointestinal research, BPC-157 Capsules function through several systemic and localized pathways:
-
Upregulation of VEGFR2: BPC-157 Capsules are studied for their ability to stimulate the expression of Vascular Endothelial Growth Factor receptor 2. This triggers angiogenesis, the formation of new blood vessels, which is essential for repairing ulcerated or damaged mucosal tissue.
-
Nitrogen Oxide (NO) Synthesis: The peptide modulates the NO system, acting as a vasodilator and protector of the endothelium. This mechanism is vital for maintaining healthy blood flow to the gastric lining.
-
Collagen and Fibroblast Activation: Research demonstrates that BPC-157 Capsules increase the recruitment of fibroblasts and the deposition of Type I collagen, accelerating the physical closure of intestinal lesions.
-
Modulation of the GABAergic System: Beyond the gut, BPC-157 Capsules are investigated for their “gut-brain” effects, specifically their ability to stabilize neurotransmitter levels and protect against CNS-induced gastric ulcers.
Primary Research Applications of BPC-157 Capsules
-
Ulcerative Colitis and Crohn’s Models: Analyzing the peptide’s efficacy in reducing inflammation and promoting mucosal “re-epithelialization.”
-
NSAID Damage Reversal: Investigating the ability of BPC-157 Capsules to counteract the erosive effects of long-term aspirin or ibuprofen use on the stomach lining.
-
Leaky Gut and Permeability: Studying the stabilization of tight junctions and the prevention of bacterial translocation.
-
Post-Surgical Gut Recovery: Observing the acceleration of healing following gastric bypass or intestinal resection surgeries.
4. Technical Specifications (E-E-A-T Data)
| Feature | Scientific Specification |
| Full Chemical Name | L-Arginine Salt of L-Valyl-L-alanyl-L-aspartyl-L-alanyl-L-phenylalanyl-L-prolyl-L-prolyl-L-prolyl-L-glycyl-L-lysyl-L-prolyl-L-alanyl-L-aspartyl-L-aspartyl-L-alanine |
| Peptide Sequence | Gly-Pro-Pro-Leu-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala |
| Molecular Formula | $C_{62}H_{98}N_{16}O_{22}$ (Peptide Base) |
| Molecular Weight | 1419.5 g/mol |
| CAS Number | 137525-51-0 |
| Counter-Ion | L-Arginine (Optimized for Gastric Stability) |
| Purity Grade | $\geq$99% (HPLC & Mass Spec Verified) |
| Physical State | Lyophilized Powder in Vegan-Grade Capsules |
| Biological Half-Life | ~4-6 Hours (Enhanced by Arginine salt stabilization) |
5. Product FAQ
Q: Why choose BPC-157 Capsules over injectable versions? A: For research specifically targeting the gastrointestinal tract, BPC-157 Capsules provide direct, localized exposure to the gastric and intestinal mucosa. While injections provide systemic benefits, the oral route is studied for its superior efficacy in treating localized gut pathologies.
Q: Are BPC-157 Capsules stable at room temperature? A: Stable Arginine-salt BPC-157 Capsules are significantly more heat-stable than the acetate form. In research settings, they can typically be stored at room temperature for short durations, though long-term storage at 4°C is recommended to maintain 99%+ purity.






Reviews
There are no reviews yet.